Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Chicken feather gene mutation helps understand human hair disorders.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Understanding hormones is key to treating certain skin conditions.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Antiandrogens can treat excess body hair and hair loss by blocking male hormones.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Finasteride improves hair but may reduce sperm quality at higher doses.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Treatments for hair loss include estrogen therapy and special shampoos.